Problem att logga in eller att hålla dig inloggad? Klicka här
Första gången du loggar in: Välj att antingen logga in med din e-post och använd ditt medlemsnummer som lösenord eller Beställ nytt lösenord för att logga in på webbplatsen.
Har du inget konto än? BLI MEDLEM HÄR
Anmälan om förvärv eller överlåtelse av finansiella instrument.
Episurf Medical (Nasdaq: EPIS B) meddelar idag att knäteknologin Episealer® kommer att presenteras vid ESSKA Speciality Days (European Society for Sports Traumatology, Knee Su...
Episurf Medical (Nasdaq: EPIS B) today announces that the Episealer® Knee technology will be presented at the ESSKA Speciality Days (European Society for Sports Traumatology, ...
Episurf Medical (Nasdaq: EPIS B) meddelar idag att bolaget avser att lämna in en 510(k)-ansökan till det amerikanska läkemedelsverket FDA under andra kvartalet 2023 för det tå...
Episurf Medical (NASDAQ: EPIS B) today announces that the company plans to file a 510(k) submission to the US FDA during Q2 2023 for the toe implant the company is currently d...
Episurf Medical (Nasdaq: EPIS B) today announces that the Indian authorities have, through their Directorate General of Health Services, Central Drugs Standard Control Organis...
Episurf Medical (Nasdaq: EPIS B) meddelar idag att indiska myndigheter, via Directorate General of Health Services, Central Drugs Standard Control Organisation (CDSCO), Medica...
Episurf Medical (Nasdaq: EPIS B) meddelar idag att företaget adderat Dr. Thomas Roukis, D.P.M., Ph.D. till sin växande grupp av internationella specialister inom nedre extremi...
Episurf Medical (Nasdaq: EPIS B) today announces that as it continues development of its MTP implant, the company has added Dr. Thomas Roukis, D.P.M., Ph.D. to its growing lis...
Episurf Medical (Nasdaq: EPIS B) will attend Redeye Life Science Day which is held on November 24th, 2022. The event is arranged by Redeye and the company will be represented ...
Episurf Medical (Nasdaq: EPIS B) deltar vid Redeye Life Science Day, som hålls den 24e november 2022. Arrangör är Redeye och bolaget företräds av bolagets Vd Pål Ryfors.
Episurf Medical hosted a CMD on 16 November at which it discussed the state of the company and its long-term plans. International expansion will be even more important in the ...
Redeye reiterates its fair value range for Episurf Medical following the Q3 report. While sales came in lower than we expected, we emphasise the earl...
Vid dagens Kapitalmarknadsdag presenterar Episurf Medical (NASDAQ: EPIS B) strategiska fokusområden inklusive geografisk expansion till nya marknader, däribland USA, samt nya ...
At today's Capital Markets Day, Episurf Medical (NASDAQ: EPIS B) presents strategic focus areas, which includes geographic expansion into new markets including The United...
